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R233Therefore, any changes observed in
blood flow measurements following
a pharmacological challenge with
psilocybinmight simply reflect changes
in vascular tone asopposed to neuronal
activity. The authors clearly anticipated
this confound, and added a control
condition, measuring BOLD signals
while the participants held their breath.
Breath holding induces hypercapnia
and vasodilatation, and allows the
assessment of vascular reactivity on
BOLD signals [8]. Importantly, breath
hold-induced BOLD responses
appeared unchanged following
psilocybin infusion, suggesting that
their results were not confounded by
changes in vascular tone.
Carhart-Harris and colleagues [2]
interpret their results in terms of
a decrease in activity in critical ‘hub’
regions of the brain, specifically, the
anterior and posterior cingulated
cortex, and a loss of coordination
between them, caused by the inhibitory
effects of serotonin 2A receptor
stimulation. This would trigger ‘‘a
state of unconstrained cognition’’.
Consistent with their findings, studies
in rats have suggested that cortical
local field potentials, which the BOLD
signal is believed to reflect, are
decreased following serotonin 2A
receptor stimulation [9]. However,
an earlier study [10] using positron
emission tomography reported
increased glucose metabolism
following psilocybin administration,
somewhat clouding the picture.
A second study from the same group
[3] focused not on brain activity in the
resting state, but studied BOLD signals
while participants were cued to recall
specific personal memories of positive
events from their life. Not only were
memories described as more vivid,
emotional and positive following
psilocybin infusion, but brain
responses were enhanced in visual and
auditory cortex during autobiographic
recollection. These findings led to
a somewhat different conclusion than
the first study, namely that psilocybin
focuses and enhances subjective and
neural responses to autobiographical
memory rather than resulting in a state
of ‘unconstrained cognition’. This stark
difference between the two sets of
experimental findings underscores the
difficulty in comparing results from
task-related fMRI, as in the second
study [3], in which the effects of an
experimental condition are compared
with a control condition, with thosefrom relatively unconstrained
resting-state fMRI.
On the basis of their results,
Carhart-Harris and colleagues [2,3]
suggest that psilocybin may have
potential efficacy in the treatment of
depression, especially when combined
with psychotherapy. This conjecture is
based mainly on their observations of
a reduction in resting-state cerebral
blood flow in the anterior cingulate
cortex, which is reliably hyperactive in
the depressed state [11]. While a recent
study [6] did report slightly lowered
depression scores 6 months after
psilocybinadministration in terminally ill
cancer patients, this study specifically
excluded individuals with a recent
major depressive episode. Therefore,
it remains tobeseenwhetherpsilocybin
might help to treat depression.
However, given the administrative
obstacles in conducting such a trial
under current regulatory frameworks,
it is unlikely that wewill witness a return
to the 1950s heyday of psychedelic
psychotherapy any time soon.References
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DOI: 10.1016/j.cub.2012.02.033Chromosomal Instability: Mad2
beyond the Spindle CheckpointWhat specific defects can cause chromosomal instability in cancer cells?
Overexpression of the mitotic checkpoint protein Mad2 triggers chromosome
missegregation but, surprisingly, Mad2 exerts this effect through a previously
unknown effect on microtubule dynamics.Edward R. Ballister1
and Michael A. Lampson1,2,*
In order to faithfully segregate
their chromosomes at each division,
cells must ensure that each pair of
sister chromatids is correctly attached
to spindle microtubules from oppositepoles before anaphase onset. Two
complementary systems collaborate
for this purpose: regulation of
kinetochore-microtubule dynamics
and the mitotic checkpoint.
Kinetochore-microtubule dynamics
are regulated to selectively
destabilize incorrect attachments,
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prevents the cell from proceeding
to anaphase until all kinetochores
are stably attached. Defects in
either of these processes could cause
the elevated rates of chromosome
instability (CIN) observed in cancers.
In this issue of Current Biology,
Kabeche and Compton [1]
investigate the cellular mechanism
of CIN induced by overexpression of
Mad2, an essential mitotic checkpoint
protein.
Although many proteins are
mutated andmisregulated in cancers, a
preponderance of evidence implicates
Mad2 overexpression as a driver of
chromosomal instability. Mad2
overexpression is particularly
associated with cancers in which the
Rb or p53 tumor suppressors have
been inactivated [2,3]. Inactivation of
either Rb or p53 causes both Mad2
overexpression and CIN, and in both
cases the CIN phenotype can be
rescued by experimentally reducing
Mad2 overexpression. Mad2
overexpression per se is sufficient to
cause CIN in vitro and in vivo [4].
Moreover, Mad2 overexpression and
concomitant CIN causes tumorigenesis
in mice, even when induced transiently,
and can increase rates of relapse after
withdrawal of a primary driver
oncogene such as KRAS [5]. The
cellular mechanism by which Mad2
overexpression causes CIN, however,
had not been directly investigated
until now.
Mad2 is a central component of the
mitotic checkpoint: it localizes to
unattached kinetochores and forms
part of the diffusible ‘wait’ signal that
inhibits the Anaphase Promoting
Complex [6]. Given Mad2’s central
function as a mitotic checkpoint
protein, it would be natural to assume
that Mad2 overexpression drives CIN
by causing a defect in the mitotic
checkpoint. The fitness of the mitotic
checkpoint is defined by two features:
the ability to generate sufficient wait
signal to prevent anaphase until all
chromosomes are attached
(checkpoint signaling) and the ability to
release this arrest and allow anaphase
to proceed swiftly once the last
chromosome has attached (checkpoint
silencing). Defects in either of these
aspects of the checkpoint could cause
CIN. Mad2-overexpressing cells can
maintain a long mitotic arrest in the
presence of nocodazole, a spindle
poison that prevents properkinetochore-microtubule attachments,
suggesting that Mad2 overexpression
does not prevent checkpoint signaling
[3]. The effect of Mad2 overexpression
on checkpoint silencing has not been
carefully measured, and remains an
interesting question.
Independent of checkpoint
function, Mad2 overexpression
could cause CIN by interfering
with kinetochore-microtubule
dynamics. Formation of proper
kinetochore-microtubule attachments
requires a finely tuned balance
between stabilizing factors and
destabilizing factors, in a model
dubbed the kinetochore-microtubule
‘stabilostat’ [7]. When stabilizing
factors are compromised or
destabilizing factors are
hyperactivated, kinetochores can
fail to bind microtubules. Conversely,
hyperstabilization of kinetochore
microtubules increases erroneous
attachments in metaphase, which
cause lagging chromosomes at
anaphase. Although lagging
chromosomes are often successfully
corrected [8], they can cause cleavage
furrow regression and consequent
tetraploidization, or they can be
pulverized by the cleavage furrow,
leading to chromosome
rearrangements [9–11]. The net
microtubule-destabilizing activity can
be experimentally determined from the
overall rates of microtubule turnover in
the spindle. Kinetochore-microtubule
hyperstabilization in cancer cell
lines strongly predicts lagging
chromosomes at anaphase, and these
defects can be rescued by expression
of targeted destabilizing factors [12].
Thus, defects in kinetochore
microtubule dynamics appear to be
a common theme underlying the
mechanisms of CIN in diverse cancers.
Kabeche andCompton [1] report that
Mad2 overexpression causes a striking
hyperstabilization of kinetochore
microtubules in prometaphase and
metaphase, and, conversely, Mad2
depletion destabilizes kinetochore
microtubules. The latter result
suggests that the influence of Mad2
on microtubule stability is a normal
Mad2 function, not a gain of function
exclusive to overexpressed Mad2.
The stabilizing effect of Mad2
overexpression can be rescued
by overexpression of MCAK, a
microtubule-destabilizing protein. The
Mad2 overexpression phenotype is
not affected, however, by depletion ofMad1, an essential checkpoint protein
upstream of Mad2 that is required for
Mad2 localization to kinetochores. This
result suggests that microtubule
stabilization induced by Mad2
overexpression does not require either
kinetochore localization or a functional
mitotic checkpoint. Mad2 regulation
of microtubule stability is therefore
a newly appreciated function that is
independent of its known checkpoint
functions.
Having established that Mad2
overexpression causes CIN via the
hyperstabilization of kinetochore
microtubules, a natural candidate to
investigate was Aurora B kinase, a key
regulator of kinetochore-microtubule
stability [13,14]. Aurora B normally
localizes to centromeres during
prometaphase and metaphase and
regulates kinetochore microtubules by
phosphorylating substrates that
interact directly with microtubules.
Inhibition of Aurora B causes increased
rates of lagging chromosomes, and
centromere localization of Aurora B,
in close proximity to its kinetochore
substrates, is essential for its function.
Kabeche and Compton [1] show that
whenMad2 is overexpressed, Aurora B
fails to localize to centromeres, and
phosphorylation of a kinetochore
substrate is reduced. These results
argue that Mad2 overexpression
exerts its influence on
kinetochore-microtubule stability by
disrupting the centromere localization
of Aurora B kinase, but it remains to
be shown that Aurora B localization
is deranged in vivo in genuine
Mad2-overexpressing cancers. It will
be interesting to see how Aurora B
localization and activity are affected
by Mad2 depletion, as it is formally
possible that Mad2 depletion might
affect microtubule stability through
a different pathway altogether.
The discovery that Mad2 can affect
Aurora B localization opens up a new
front in the larger effort to understand
how Aurora B localization is regulated
throughout the cell cycle. Aurora B is
part of the Chromosome Passenger
Complex (CPC) along with INCENP,
Survivin, and Borealin. We now know
that CPC localization to the inner
centromere is determined by the
coincidence of two histone
modifications: the phosphorylation
of H2A-Thr120 and H3-Thr3 by the
kinases Bub1 and Haspin, respectively
[15–17]. It will be interesting to
determine whether Bub1 or Haspin
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R235localization, or activity, are affected
by Mad2 levels. It was recently found
that diploid, nontransformed cell lines
can dynamically regulate CPC levels
at individual centromeres in response
to the microtubule attachment state,
but this regulation fails in the cancer
cell lines that have been examined [18].
The newly discovered connections
between Mad2 and Aurora B in the
larger context of CIN and cancer
herald an exciting area for further
exploration.
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Day, Stochastic the NextThree recent papers provide striking insight into the mechanisms used to
regulate B-cell differentiation. They demonstrate that B-cell fate choice can be
stochastic, directed, inherited, or somecombination of these, depending on the
circumstances. The trick is going to be working out which is important when.David Tarlinton
A central goal of biological research
is to understand fate determination
of cells during development. Fate
determination in immunology is
apparent in the pluripotency of
haematopoietic stem cells, in the
development of distinct cell types
within lineages, such as T-cell
bifurcation into CD4+ and CD8+
compartments, and in the capacity of
mature leukocytes to differentiate into
effector cells in response to external
stimuli. It is through this last prism that
three recent papers in Science [1–3]
can be viewed, with each providing
a distinct perspective on the
mechanisms that are available to
the immune system to ensure thatits responses to a potentially infinite
variety of challenges are rapid,
encompassing, efficient and flexible.
Three groups have used B cells to
address how complex patterns of
differentiation are regulated [1–3]. In
response to antigen-mediated stimuli,
naı¨ve B cells undergo well-defined
changes, including proliferation,
immunoglobulin (Ig) class switch
recombination (a process that
diversifies antibody function),
differentiation into antibody-secreting
plasma cells and into memory B cells,
and death (reviewed in [4]). B-cell
responses directed against protein
antigens require signals from CD4+ T
helper cells, help the B cells solicit
by presenting a peptide derived from
the antigen to the CD4+ T cells. TheCD4+ T cells, independently activated
by interaction with dendritic cells
presenting the same peptide,
recognise and respond to the B-cell
request by providing mitogenic and
differentiation signals, usually in the
form of the CD40 ligand (CD40L) and
cytokines, including interleukin-4
(IL-4) and IL-21. Thus, a population
of essentially homogeneous, resting,
non-secreting B cells expressing IgM
and IgD, under the guidance and
proliferative impetus of CD4+ T cells,
generates a population of
antigen-specific, B-lineage cells
that include cells that secrete
antibodies (plasma cells), cells that
have undergone class switch
recombination, cells that persist for
years in a resting state (memory
B cells), and cells that die. These
outcomes are not mutually exclusive
but instead overlap in all combinations.
The intersection of these four
processes of proliferation,
differentiation, class switch
recombination and death thus
constitutes an immune response in
all its diversity, and the appropriate
regulation of magnitude, duration,
